- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05530733
Clinical Effects of Pacifier Use in Preterm During Orogastric Tube Feeding
September 6, 2022 updated by: Yeliz Taşdelen, Zonguldak Bulent Ecevit University
The purpose of the study was to assess how preterm babies' vital signs, feeding time, and gastric residual volume were affected by using a pacifier only or a pacifier with breast milk during orogastric tube feeding.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
90
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Kozlu
-
Zonguldak, Kozlu, Turkey
- Yeliz Taşdelen
-
Contact:
- Aysel Topan, PhD, RN
- Phone Number: +90 3722613394
- Email: aysel.topan@beun.edu.tr
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
10 months to 9 months (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Feeding with the orogastric tube
- Breastmilk along with formula (babies who receive more than 50% of their total feed in 24 hours from formula)
- Gestation week between 29+0 weeks and 34+0 weeks
- Weight of 1000 g or more
Exclusion Criteria:
- Receiving mechanical ventilator support
- Development of sepsis
- Presence of neurological disease
- Presence of chromosomal or congenital anomalies
- Presence of intraventricular bleeding
- Unstable physiological parameters
- No breast milk
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Pacifier only
Participants in the pacifier-only group will get a pacifier five minutes prior to tube feeding.
During feedings, a pacifier will be employed.
Five minutes following the end of tube feeding, the pacifier application will be discontinued.
The vital signs will be monitored prior to, during, and following feeding.
Two hours after the feeding has finished, the volume of gastric residue will be controlled.
|
Pacifiers produced for premature babies will be used in the study.
Pacifiers will be made of silicone material suitable for premature baby health and will not contain any harmful substances.
A separate pacifier will be used for each baby, and pacifiers will be sterilized before use.
|
Other: Pacifier with breast milk
Five minutes prior to tube feeding, participants in the pacifier with breast milk group will get their own breast milk dripping pacifier.
During feedings, a pacifier will be employed.
Five minutes following the end of tube feeding, the pacifier application will be discontinued.
The vital signs will be monitored prior to, during, and following feeding.
Two hours after the feeding has finished, the amount of gastric residue will be controlled.
|
Pacifiers produced for premature babies will be used in the study.
Pacifiers will be made of silicone material suitable for premature baby health and will not contain any harmful substances.
A separate pacifier will be used for each baby, and pacifiers will be sterilized before use.
For babies assigned to the pacifier with breast milk group, their own breast milk will be applied by dripping 1 ml into the pacifier.
|
No Intervention: standard care (no pacifier)
The premature babies in the standard care (no pacifier) will get standard care while being fed through an orogastric tube.
The vital signs will be monitored prior to, during, and following feeding.
Two hours after the feeding has finished, the amount of gastric residue will be controlled.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Heart rate change
Time Frame: 5 minutes before tube feeding, during tube feeding and 5 minutes after tube feeding
|
Heart rate will be measured 5 minutes before tube feeding, during tube feeding and 5 minutes after the end of tube feeding.
|
5 minutes before tube feeding, during tube feeding and 5 minutes after tube feeding
|
Respiratory rate change
Time Frame: 5 minutes before tube feeding, during tube feeding and 5 minutes after tube feeding
|
Respiratory rate will be measured 5 minutes before tube feeding, during tube feeding and 5 minutes after the end of tube feeding.
|
5 minutes before tube feeding, during tube feeding and 5 minutes after tube feeding
|
Saturation level change
Time Frame: 5 minutes before tube feeding, during tube feeding and 5 minutes after tube feeding
|
Saturation level will be measured 5 minutes before tube feeding, during tube feeding and 5 minutes after the end of tube feeding.
|
5 minutes before tube feeding, during tube feeding and 5 minutes after tube feeding
|
Feeding duration
Time Frame: measured with a stopwatch for 7 months.
|
Each baby's tube feeding duration will be measured.
|
measured with a stopwatch for 7 months.
|
Gastric residual volume
Time Frame: Gastric residue will be measured 2 hours after the end of infant feeding.
|
Gastric residue will be measured 2 hours after the end of infant feeding.
|
Gastric residue will be measured 2 hours after the end of infant feeding.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
September 1, 2022
Primary Completion (Anticipated)
March 1, 2023
Study Completion (Anticipated)
June 1, 2023
Study Registration Dates
First Submitted
August 29, 2022
First Submitted That Met QC Criteria
September 6, 2022
First Posted (Actual)
September 7, 2022
Study Record Updates
Last Update Posted (Actual)
September 7, 2022
Last Update Submitted That Met QC Criteria
September 6, 2022
Last Verified
September 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- BEU-YTASDELEN-001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Premature
-
Ascendance BiomedicalCompletedInfertility | Menopause | Menopause, Premature | Infertility, Female | Premature Ovarian Failure | Menopause Related Conditions | Perimenopausal Disorder | Infertility Unexplained | Menopause Premature Symptomatic | Menopause Premature Asymptomatic | Premature Ovarian Failure, Familial | Premature Ovarian Failure... and other conditionsUnited States
-
Forever Young d.o.o.Medigroup Health System, Jevremova hospital; Saint James Hospital Malta; Re-medika...UnknownMenopause | Menopause, Premature | Premature Ovarian Failure | Ovarian Failure, Premature | Ovarian Failure | Ovarian Insufficiency | Ovarian Insufficiency, Primary | Premature Ovarian Failure 2A | Premature Ovarian Failure 3 | Premature Ovarian Failure 4 | Premature Ovarian Failure 1 | Premature Ovarian Failure... and other conditionsMalta, North Macedonia, Serbia
-
GlaxoSmithKlineCompletedObstetric Labour, Premature | Premature LaborUnited States
-
Assistance Publique Hopitaux De MarseilleUnknownPremature LabourFrance
-
Assiut UniversityNot yet recruitingPremature Rupture of Membrane
-
Cairo UniversityCompletedPremature Rupture of MembraneEgypt
-
University of OklahomaIndiana University School of MedicineCompletedPreterm Premature Rupture of Membranes
-
Centre Hospitalier Universitaire, AmiensCompletedPremature InfantFrance
-
Marmara UniversityCompleted
-
University Hospital, LimogesCompleted
Clinical Trials on Pacifier
-
Acibadem UniversityCompleted
-
Englewood Hospital and Medical CenterCompleted
-
Fundación para el Estudio y Prevención de la Muerte...Hospital Italiano de Buenos Aires; Fundacion para la Salud Materno InfantilUnknown
-
University of California, DavisYale University; Benedictine UniversityWithdrawnPostpartum Depression | BreastfeedingUnited States
-
Bambino Gesù Hospital and Research InstituteArtsana S.p.a.RecruitingSleep | Gait | Muscle Relaxation | Electroencephalography | Postural Balance | Non-nutritive SuckingItaly
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaCompletedGastroesophageal Reflux | Bradycardia | ApneasItaly
-
University of Missouri-ColumbiaUniversity of GeorgiaRecruitingPreterm Birth | Bronchopulmonary Dysplasia | Chronic Lung Disease of Prematurity | Respiratory Distress Syndrome in Premature InfantUnited States
-
Nationwide Children's HospitalCerebral Palsy AllianceCompletedInfarction | Thrombosis | Intraventricular Hemorrhage | Neonatal Encephalopathy | Infant Development | Hydrocephalus | Infant,Premature | PVLUnited States
-
University of Nebraska LincolnTufts Medical Center; Texas Tech University; Children's Hospital of Orange County and other collaboratorsCompletedInfant, Extremely Low Birth Weight | Feeding BehaviorUnited States
-
Norwegian University of Science and TechnologySt. Olavs HospitalCompleted